Endoscopic RFA is an advanced treatment modality, which is commonly applied in the treatment of medical indication such as uncoordinated heartbeats, Barrett's esophagus, and pain management, and others. Radiofrequency ablation is considered to be an FDA-approved advanced endoscopic technique in which the diseased tissue is exposed to heat energy for its destruction or removal. The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567.4 million in 2017 and is estimated to reach at $7,471.5 million by 2025, registering a CAGR of 9.6% from 2018 to 2025. Research Beam Model: Research Beam Product ID: 3113895 5370 USD New
Endoscope + Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications, Pain Management, Oncology Applications, and Other Applications) - Global Opportunity Analysis and Industry Forecast, 2017-2025
 
 

Endoscope + Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications, Pain Management, Oncology Applications, and Other Applications) - Global Opportunity Analysis and Industry Forecast, 2017-2025

  • Category : Healthcare
  • Published On : July   2018
  • Pages : 75
  • Publisher : Allied Market Research
 
 
 

Endoscopic RFA is an advanced treatment modality, which is commonly applied in the treatment of medical indication such as uncoordinated heartbeats, Barrett's esophagus, and pain management, and others. Radiofrequency ablation is considered to be an FDA-approved advanced endoscopic technique in which the diseased tissue is exposed to heat energy for its destruction or removal. The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567.4 million in 2017 and is estimated to reach at $7,471.5 million by 2025, registering a CAGR of 9.6% from 2018 to 2025.

Upsurge in geriatric population that is highly susceptible to pain and chronic disorders has a positive impact on the market growth. In addition, rise in need for the development of advanced minimally invasive surgical techniques has propelled the demand for endoscopic RFA across healthcare settings, thus fueling the market growth.

However, dearth of skilled professionals that lack complete know-how of endoscopic RFA treatment impedes the market growth. Conversely, high untapped potential in the emerging economies is anticipated to offer significant profitable opportunities for the expansion of the market.

The endoscope + radiofrequency ablation (RFA) market is segmented based on application. On the basis of application, the market is categorized into cardiology applications, pain management, oncology applications, and others.

KEY BENEFITS

  • This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global endoscope + radiofrequency ablation (RFA) market.
  • Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
  • A qualitative analysis based on innovative products and devices facilitate the strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Application

  • Cardiology Applications
  • Pain Management
  • Oncology Applications
  • Other Applications

KEY MARKET PLAYERS

  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic Plc.
  • Smith & Nephew Plc.
  • Stryker Corporation

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Endoscope + radiofrequency ablation (RFA) market: Innovative products

3.2.1. Barex 360
3.2.2. Habib EUS RFA catheter
3.2.3. Temperature-resistant probes

3.3. Clinical trials: RFA and RFA + endoscope products in pipeline
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in the prevalence of cancer and cardiac ailments across the globe
3.4.1.2. Large scale adoption of endoscopic RFA devices in pain management
3.4.1.3. High efficacy and short duration of the procedure

3.4.2. Restraints

3.4.2.1. High costs associated with the RFA treatment
3.4.2.2. Limited awareness regarding available RFA + endoscope devices

3.4.3. Opportunity

3.4.3.1. Emerging indications for the endoscopic radiofrequency ablation

CHAPTER 4: ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET, BY APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Oncology application

4.2.1. Market size and forecast

4.3. Pain management

4.3.1. Market size and forecast

4.4. Cardiology application

4.4.1. Market size and forecast

4.5. Other applications

4.5.1. Market size and forecast

CHAPTER 5: COMPANY PROFILES

5.1. Boston Scientific Corporation

5.1.1. Company overview
5.1.2. Company snapshot
5.1.3. Operating business segment
5.1.4. Business performance
5.1.5. Key strategic moves and developments

5.2. Conmed Corporation

5.2.1. Company overview
5.2.2. Company snapshot
5.2.3. Operating business segment
5.2.4. Business performance
5.2.5. Key strategic moves and developments

5.3. Medtronic Plc

5.3.1. Company overview
5.3.2. Company snapshot
5.3.3. Operating business segment
5.3.4. Business performance
5.3.5. Key strategic moves and developments

5.4. Smith & Nephew Plc

5.4.1. Company overview
5.4.2. Company snapshot
5.4.3. Operating business segment
5.4.4. Business performance

5.5. Stryker Corporation

5.5.1. Company overview
5.5.2. Company snapshot
5.5.3. Operating business segments
5.5.4. Business performance
5.5.5. Key strategic moves and developments

LIST OF TABLES

TABLE 01. CLINICAL TRIALS, RADIOFREQUENCY ABLATION DEVICES MARKET, 2013-2016
TABLE 02. GLOBAL ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 03. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
TABLE 04. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR PAIN MANAGEMENT, BY REGION, 2017-2025 ($MILLION)
TABLE 05. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
TABLE 06. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
TABLE 07. BOSTON: COMPANY SNAPSHOT
TABLE 08. BOSTON: OPERATING SEGMENT
TABLE 09. CONMED: COMPANY SNAPSHOT
TABLE 10. CONMED: OPERATING SEGMENT
TABLE 11. MEDTRONC: COMPANY SNAPSHOT
TABLE 12. MEDTRONIC: OPERATING SEGMENT
TABLE 13. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 14. SMITH: OPERATING SEGMENT
TABLE 15. STRYKER: COMPANY SNAPSHOT
TABLE 16. STRYKER: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 01. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET SEGMENTATION
FIGURE 02. RECENT PRODUCT LAUNCHES
FIGURE 01. RESTRAINTS AND DRIVERS: GLOBAL ENDOSCOPE+RFA MARKET
FIGURE 02. GLOBAL ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET, 2017-2025 ($MILLION)
FIGURE 03. . ESTIMATED NEW CANCER CASES AND DEATHS, 2017: U.S.
FIGURE 04. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR ONCOLOGY APPLICATIONS, 2017-2025 ($MILLION)
FIGURE 05. RADIOFREQUENCY ABLATION FOR CHRONIC PAIN MANAGEMENT
FIGURE 06. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR PAIN MANAGEMENT, 2017-2025 ($MILLION)
FIGURE 07. FREQUENCY OF ATRIAL FIBRILLATION AMONG PATIENTS WITH ISCHEMIC STROKE, 2013-2014
FIGURE 08. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR CARDIOLOGY APPLICATIONS, 2017-2025 ($MILLION)
FIGURE 09. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR OTHER APPLICATIONS, 2017-2025 ($MILLION)
FIGURE 10. BOSTON: NET SALES, 2015-2017($MILLION)
FIGURE 11. BOSTON: REVENUE SHARE PER SEGMENT 2017(%)
FIGURE 12. BOSTON: REVENUE SHARE BY GEOGRAPHY 2017(%)
FIGURE 13. CONMED: NET SALES, 2015-2017 ($MILLION)
FIGURE 14. CONMED: REVENUE BY SEGMENT, 2016 (%)
FIGURE 15. CONMED: NET SALES, 2015-2017 ($MILLION)
FIGURE 16. MEDTRONIC: NET SALES, 2015-2017($MILLION)
FIGURE 17. MEDTRONIC: REVENUE SHARE PER SEGMENT 2017(%)
FIGURE 18. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY 2017(%)
FIGURE 19. SMITH & NEPHEW: NET SALES, 2015-2017($MILLION)
FIGURE 20. SMITH & NEPHEW: REVENUE SHARE PER SEGMENT 2017(%)
FIGURE 21. SMITH & NEPHEW: REVENUE SHARE BY GEOGRAPHY 2017(%)
FIGURE 22. STRYKER: NET SALES, 2015-2017($MILLION)
FIGURE 23. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 24. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2017(%)

PURCHASE OPTIONS
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT